BE
HeartBeam, Inc.
BEAT · NASDAQ
$0.40 -6.30% (-$0.03)
1M -16.62%
Market Cap $23.3M
P/E Ratio -
Div. Yield -
ROE 686.78%
Bulios Fair Price
$0.22
45.4% downside
Current Price
$0.4
Undervalued Fair Value Overvalued
According to Bulios Fair Price, BEAT is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
69 /100
Cheap P/B 2.85x
P/E N/A
EV/EBITDA N/A
Growth
41 /100
Stable Book val. growth 3.12%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
FCF margin N/A
Quality
0 /100
Poor ROIC 249.58%
ROE 686.78%
Asset turnover 0.00x
Debt
100 /100
Low Debt/Equity 0.00x
Current ratio 3.66x
Int. coverage N/A
Stability
49 /100
Moderate Beta -0.80x
EPS volatility 28.84%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BEAT
Online
Sector
Healthcare
Industry
Medical - Specialties
CEO
Branislav Vajdic
Employees
16
Headquarters
Santa Clara
Upcoming events
12 NOV
Earnings
Upcoming earnings report